Article
FGFR1 actionable mutations, molecular specificities, and outcome of adult midline gliomas.
Neurology - 5 Jun 2018
Picca Alberto, Berzero Giulia, Bielle Franck, Touat Mehdi, Savatovsky Julien, Polivka Marc, Trisolini Elena, Meunier Sheida, Schmitt Yohann, Idbaih Ahmed, Hoang-Xuan Khe, Delattre Jean-Yves, Mokhtari Karima, Di Stefano Anna Luisa, Sanson Marc
Abstract excerpt
OBJECTIVE: To characterize the prevalence and prognostic significance of major driver molecular alterations in adult midline diffuse gliomas (MLG). METHODS: Adults with histologically proven MLG diagnosed between 1996 and 2017 were identified from our tumor bank, systematically reviewed, and reclassified according to WHO 2016. Targeted sequencing was performed, including determination of H3F3A, HIST1H3B, TERTp,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
